Related Experiment Video
Updated: Apr 12, 2026

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.5K
Obesity management in Prader-Willi syndrome
Pediatric Endocrinology Reviews : PER
|May 13, 2015
Summary
Prader-Willi Syndrome (PWS) causes genetic obesity with unique hyperphagia and low energy expenditure. Current management is limited, but new treatments for PWS hyperphagia and obesity show promise.
Area of Science:
- Genetics
- Endocrinology
- Neuroscience
Background:
- Prader-Willi Syndrome (PWS) is a common genetic disorder.
- PWS is characterized by a unique obesity phenotype, including hyperphagia and reduced energy expenditure.
- The relentless food-seeking behavior in PWS presents significant challenges for patients and caregivers.
Purpose of the Study:
- To review the unique characteristics of obesity in PWS.
- To discuss current management strategies for PWS-related obesity and hyperphagia.
- To highlight the need for and potential of new therapeutic options.
Main Methods:
- Literature review of PWS genetics, phenotype, and management.
- Analysis of research on hyperphagia and obesity in PWS.
- Synthesis of current therapeutic approaches and future research directions.
Main Results:
- PWS obesity involves hyperphagia, altered meal patterns, reduced energy expenditure, and abnormal brain responses to food.
- Current management relies on dietary restriction and behavioral interventions.
- Limited medical therapies are available, underscoring the need for new treatments.
Conclusions:
- Obesity management in PWS is critical to prevent morbidity.
- Novel therapeutic strategies targeting hyperphagia and obesity in PWS are under investigation.
- Future research holds promise for improved PWS treatment options.
Related Concept Videos
Obesity
1.6K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.6K
Drug Dosing: Obese Patients
349
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
349
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
404
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
404
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
303
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
303
Bulimia Nervosa
1.1K
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
1.1K
Cystic Fibrosis: Management
636
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
636

